Home › NDC Lookup › RxCUI directory › RxCUI 2691689

Acetaminophen 325 MG / diphenhydramine hydrochloride 12.5 MG Chewable Tablet — RxCUI 2691689

RxNorm drug concept · Semantic clinical drug
RxCUI 2691689 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2691689
Official nameAcetaminophen 325 MG / diphenhydramine hydrochloride 12.5 MG Chewable Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 325 MG / diphenhydramine hydrochloride 12.5 MG Chewable Tablet; acetaminophen 325 MG / diphenhydrAMINE HCl 12.5 MG Chewable Tablet
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Diphenhydramine Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It gives temporary relief of pain and itching on the skin. That includes minor burns, minor cuts or scrapes, insect bites, minor skin irritations, and rashes from poison ivy, oak o...
  • Adults and children 2 and older can apply it to the affected area no more than 3 to 4 times a day. Don't use it more often than directed. For a child under 2, check with a doctor f...
  • No. Don't use it on large areas of the body or on broken, blistered or oozing skin. Also avoid it on chicken pox or sunburn.
  • Can I put it on a large area or on blistered skin?
📖 Read our full Diphenhydramine Topical guide →

🕸️ Concept Web — How Acetaminophen 325 MG / diphenhydramine hydrochlo... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acetaminophen 325 MG / diphenhydramine hydrochloride 12.5 MG Chewable Tablet RxCUI 2691689

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Acetaminophen 161
    • Diphenhydramine 3498
    • Acetaminophen / diphenhydramine 214181
    • Diphenhydramine hydrochloride 1362
  2. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acetaminophen / diphenhydramine Chewable Tablet 2691686
    • Acetaminophen / diphenhydramine hydrochloride Chewable Tablet 2691688
    • Acetaminophen / diphenhydramine Chewable Product 2691685
    • Acetaminophen / diphenhydramine Oral Product 1151204
    • Acetaminophen / diphenhydramine Pill 1151205
    • Acetaminophen / diphenhydramine hydrochloride Chewable Product 2691687
    • Acetaminophen / diphenhydramine hydrochloride Oral Product 2662609
    • Acetaminophen / diphenhydramine hydrochloride Pill 2662105
    • +4 more in this family
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Acetaminophen 325 MG 315263
    • Diphenhydramine hydrochloride 12.5 MG 882503

Showing up to 8 concepts per family — 14 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Acetaminophen 325 MG SCDC · 315263
  • Diphenhydramine hydrochloride 12.5 MG SCDC · 882503
  • Acetaminophen / diphenhydramine Chewable Tablet SCDF · 2691686
  • Acetaminophen / diphenhydramine hydrochloride Chewable Tablet SCDFP · 2691688
  • Acetaminophen / diphenhydramine Chewable Product SCDG · 2691685
  • Acetaminophen / diphenhydramine Oral Product SCDG · 1151204
  • Acetaminophen / diphenhydramine Pill SCDG · 1151205
  • Acetaminophen / diphenhydramine hydrochloride Chewable Product SCDGP · 2691687
  • Acetaminophen / diphenhydramine hydrochloride Oral Product SCDGP · 2662609
  • Acetaminophen / diphenhydramine hydrochloride Pill SCDGP · 2662105

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2691689 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00067-0112-01 20 TABLET, CHEWABLE in 1 BOTTLE (0067-0112-01) Theraflu Severe Cold Relief Nighttime Soft Chews Haleon US Holdings LLC 2024-09-30
Observed labelers: Haleon US Holdings LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.